Enhancing value of quality assurance rounds in improving radiotherapy management: a retrospective analysis from King Hussein Cancer Center in Jordan
Jamal K Khader et al.Radiat Oncol J.2019 Mar.
Free PMC article
Purpose: The quality assurance (QA) chart rounds are multidisciplinary meetings to review radiation therapy (RT) treatment plans. This study focus on describing the changes in RT management based on QA round reviews in a single institution.
Materials and methods: After 9 full years of implementation, a retrospective review of all patients whose charts passed through departmental QA chart rounds from 2007 to 2015. The reviewed cases were presented for RT plan review; subcategorized based on decision in QA rounds into: approved, minor modifications or major modifications. Major modification defined as any substantial change which required patient re-simulation or re-planning prior to commencement of RT. Minor modification included treatment plan changes which didn't necessarily require RT re-planning.
Results: Overall 7,149 RT treatment plans for different anatomical sites were reviewed at QA rounds. From these treatment plans, 6,654 (93%) were approved, 144 (2%) required minor modifications, while 351 (5%) required major modifications. Major modification included changes in: selected RT dose (96/351, 27%), target volume definition (127/351, 36%), organs-at-risk contouring (10/351, 3%), dose volume objectives/constraints criteria (90/351, 26%), and intent of treatment (28/351, 8%). The RT plans which required major modification according to the tumor subtype were as follows: head and neck (104/904, 12%), thoracic (12/199, 6%), gastrointestinal (33/687,5%), skin (5/106, 5%), genitourinary (16/359, 4%), breast (104/2387, 4%), central nervous system (36/846, 4%), sarcoma (11/277, 4%), pediatric (7/251, 3%), lymphoma (10/423, 2%), gynecological tumors (2/359, 1%), and others (11/351, 3%).
Conclusion: Multi-disciplinary standardized QA chart rounds provide a comprehensive and an influential method on RT plans and/ or treatment decisions.
Marks LB, Light KL, Hubbs JL, et al. The impact of advanced technologies on treatment deviations in radiation treatment delivery. Int J Radiat Oncol Biol Phys. 2007;69:1579–86. - PubMed
Jaradat I, Mula-Hussain L, Wadi-Ramahi S, et al. Practical steps for establishing ocular plaque therapy in developing countries. Brachytherapy. 2012;11:230–6. - PubMed
Khader J, Al-Mousa A, Hijla FA, et al. Requirements and implementation of a lung SBRT program in a developing country: benefits of international cooperation. Int J Radiat Oncol Biol Phys. 2016;95:1236–8. - PubMed
Salem A, Al-Rashdan A, Jaradat I, Hashem SA, Almousa A. Intensity-modulated radiotherapy in head and neck cancer: how safe is safe? Hematol Oncol Stem Cell Ther. 2011;4:192. - PubMed
World Health Organization . Radiotherapy risk profile technical manual. Geneva, Switzerland: World Health Organization; 2008.